Study of Tongxinluo capsules to prevent artery re-narrowing after stenting
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests if a traditional Chinese medicine, Tongxinluo, can help prevent the artery from narrowing again after a stent procedure in the brain or neck. It's for people who have had a stroke or are at risk and recently got a stent.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosed with artery narrowing in the brain or neck that needed a stent
- Aged 45 to 80 years old
- Able to take statins and blood thinners without serious problems
- No recent bleeding or bleeding disorders
- No severe heart, liver, or kidney problems, and blood pressure and diabetes are well controlled
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether Xuesaitong Soft Capsules can help people who recently had a heart attack or unstable angina and received a stent. It aims to see if adding this medicine improves recovery and reduces future heart problems.
This study records outcomes for people with significant narrowing in brain arteries who have treatment using a drug-eluting stent. It may help doctors understand how well this approach works and what risks or benefits to expect.
This study tests a special balloon-expandable stent to treat narrowed arteries in the brain that have not improved with medication. It aims to help people who have had strokes or TIAs despite taking medicines for risk factors like high blood pressure or diabetes.
This study tests whether a Chinese herbal capsule, Getong Tongluo, can help people recover from a recent ischemic stroke (a stroke caused by a blocked blood vessel in the brain). Researchers want to see if it improves symptoms and understand how it works.
This study compares a drug-coated stent placed in a neck (vertebral) artery versus best medical treatment with medicines and risk-factor control. It aims to reduce problems caused by a badly narrowed artery after recent stroke-like symptoms.
This trial studies whether an intracranial stent (a small mesh tube placed inside the brain artery) improves outcomes and safety for people with severe, symptomatic narrowing of brain arteries. It may help if symptoms continue despite antiplatelet medicine or if blood flow to the brain is poor.
Hear when a new Stent Restenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.